Efficacy of Selumetinib in Reducing Plexiform Neurofibroma Volume in Adults with Neurofibromatosis Type 1 By Ogkologos - July 1, 2025 479 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the KOMET study Source RELATED ARTICLESMORE FROM AUTHOR Adding Epcoritamab to Lenalidomide and Rituximab Results in Higher Response Rate and Longer PFS in Patients with Relapsed or Refractory Follicular Lymphoma Patient Guide in Prostate Cancer Now Available in Vietnamese One Dose of Either a Bivalent or Nonavalent HPV Vaccine Provides Protection Against HPV16 or HPV18 Infection and Is Not Inferior To Two Doses MOST POPULAR A Clinical Signal of Efficacy Observed with a Combination of Nivolumab... June 20, 2022 Forging Military Partnerships to Empower the Cancer Research Enterprise March 27, 2018 Overcoming a Cancer Nemesis? KRAS Inhibitor Shows Promise in Early Trial December 5, 2019 A Phase III Study of Spartalizumab in Combination with Dabrafenib and... January 20, 2022 Load more HOT NEWS FDA Approves Capmatinib for Metastatic NSCLC Your questions on our research strategy A Safer, Better Treatment Option for Some Younger Women with Breast... Research with integrity – why colour blindness is a research integrity...
